Insider Trends: Insider at AtriCure Converts Options in Mist of 90-Day Buying Trend
08:20 AM EDT, 05/10/2021 (MT Newswires) -- Mark A Collar, Director, exercised options for 10,000 shares in AtriCure (ATRC) for $141,700 on May 06, 2021. Collar, subsequent to the transactions described in the SEC Form 4 filing, has control over 87,858 shares of the company of which 82,558 shares are held directly and 5,300 shares are controlled indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $6.82 million.
During the most recent 90-day period, previous to the date of this filing, there have been 16 insider transactions reported to the SEC for AtriCure. These transactions came from the activities of 7 individual insiders that resulted in a net disposition of 8,179 company shares. In the preceding 90-day window of time, there were 20 transactions from 6 insiders and resulted in the net disposition of 47,105 shares.
This is a lower level of transactions than the peer group average in the 93-company Medical Equipment, Supplies & Distribution peer group over the last 90-day period. Within the peer group activity averaged 105.1 transactions per company, and disposition of 9,326 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1323885/000120919121031116/xslF345X03/doc4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.